Stifel Financial Corp Acadia Pharmaceuticals Inc Transaction History

Stifel Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $794,101 - $1.24 Million	-21,804 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $30,073 - $40,391	766 Added 3.64%	21,804 $1.06 Million
Q1 2020 May 14, 2020	SELL	$31.65 - $46.87 $201,009 - $297,671	-6,351 Reduced 23.19%	21,038 $886,000
Q4 2019 Feb 13, 2020	BUY	$36.21 - $51.4 $759,106 - $1.08 Million	20,964 Added 326.29%	27,389 $1.17 Million
Q3 2019 Nov 13, 2019	BUY	$22.22 - $44.01 $142,763 - $282,764	6,425 New	6,425 $227,000
Q4 2018 Feb 13, 2019	SELL	$14.32 - $22.92 $166,913 - $267,155	-11,656 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$13.03 - $21.81 $151,877 - $254,217	11,656 New	11,656 $244,000
Q4 2017 Feb 14, 2018	SELL	$26.84 - $39.14 $197,891 - $288,579	-7,373 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$29.49 - $38.37 $217,429 - $282,902	7,373	7,373 $0

325

165M

855K

350K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.38B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.